Brief: Arecor Therapeutics Announces Royalty Financing Agreement With Ligand To Raise Up To $11 Mln
Sept 25 (Reuters) - Arecor Therapeutics PLC AREC.L: ARECOR THERAPEUTICS - CO-DEVELOPMENT AGREEMENT & MONETISATION DEAL ARECOR THERAPEUTICS: ROYALTY FINANCING AGREEMENT WITH LIGAND PHARMACEUTICALS INCORPORATED WHICH WILL RAISE NON-DILUTIVE CAPITAL OF UP TO $11 MILLION Source text: ID:nRSY7141Aa Further company coverage: AREC.L ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Ligand Pharmaceuticals Incorporated
See all newsBrief: Ligand Acquires Royalty And Milestone Interest In Santen’s Ryjunea From Sydnexis For $23 Million
Ligand Pharmaceuticals Incorporated reports results for the quarter ended June 30 - Earnings Summary
Ligand Pharmaceuticals Q2 revenue rises on royalty growth
Brief: Ligand Pharmaceuticals Q2 EPS USD 2.22
U.S. RESEARCH ROUNDUP-Equinix, Goldman Sachs, JPMorgan